|

SOF-SKN 1% Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Noxopharm Limited1

Indications

  • Cutaneous Lupus Erythematosus1
  • Lupus1

Other1 trial

Clinical Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of SOF-SKN in Healthy Participants
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.